Exercising regularly has a wide range of beneficial health effects; in particular, it has been well documented to help in the management of chronic illnesses including asthma. However, in some individuals, exertion can also trigger an exacerbation of asthmatic episodes and subsequent acute attacks of breathlessness, coughing, tightness of the chest and wheezing. This physiological process is called exercise-induced bronchoconstriction (EIB) whereby post-exercise forced expiratory volume in 1 s is reduced by 10-15% from baseline. While EIB is highly prevalent in asthmatics and presents with similar respiratory symptoms, asthma and EIB are not mutually exclusive. The aim of this review is to present a broad overview of both conditions in order to enhance the understanding of the similarities and differences distinguishing them as two separate entities. The pathophysiology and mechanisms underlying asthma are well described with research now focussing on defining phenotypes for targeted management strategies. Conversely, the mechanistic understanding of EIB remains largely under-described. Diagnostic pathways for both are established and similar, as are pharmacologic and non-pharmacologic treatments and management approaches, which have enhanced success with early detection. Given the potential for exacerbation of asthma, exercise avoidance is common but counterproductive as current evidence indicates that it is well tolerated and improves quality of life. Literature supporting the benefit of exercise for EIB sufferers is at present favourable, yet extremely limited; therefore, future research should be directed in this area as well as towards further developing the understanding of the pathophysiology and mechanisms underpinning both EIB and asthma.

Keywords:
Asthma bronchoconstriction, Respiratory illness, Inflammation
1.
World Health Organization: Global Recommendations on Physical Activity for Health. Geneva, World Health Organization, 2010.
2.
Jankowski M, Niedzielska A, Brzezinski M, Drabik J: Cardiorespiratory fitness in children: a simple screening test for population studies. Pediatr Cardiol 2015;36:27-32.
3.
Carson KV, Chandratilleke MG, Picot J, et al: Physical training for asthma. Cochrane Database Syst Rev 2013;9:CD001116.
4.
Global Initiative for Asthma (GINA): Global Strategy for Asthma Management and Prevention. 2014.
5.
Park HK, Jung JW, Cho SH, et al: What makes a difference in exercise-induced bronchoconstriction: an 8 year retrospective analysis. PLoS One 2014;9:e87155.
6.
Weiler JM, Anderson SD, Randolph C, et al: Pathogenesis, prevalence, diagnosis, and management of exercise-induced bronchoconstriction: a practice parameter. Ann Allergy Asthma Immunol 2010;105(6 suppl):S1-S47.
7.
Stevens A, Lowe J, Scott I: Core Pathology, ed 3. Elsevier, 2009.
8.
Krafczyk MA, Asplund CA: Exercise-induced bronchoconstriction: diagnosis and management. Am Fam Physician 2011;84:427-434.
9.
Crapo RO, Casaburi R, Coates AL, et al: Guidelines for methacholine and exercise challenge testing - 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161:309-329.
10.
Rundell KW, Slee JB: Exercise and other indirect challenges to demonstrate asthma or exercise-induced bronchoconstriction in athletes. J Allergy Clin Immunol 2008;122:238-246, quiz 247-248.
11.
Weiler JM, Bonini S, Coifman R, et al: American Academy of Allergy, Asthma & Immunology Work Group report: exercise-induced asthma. J Allergy Clin Immunol 2007;119:1349-1358.
12.
Stickland MK, Rowe BH, Spooner CH, et al: Effect of warm-up exercise on exercise-induced bronchoconstriction. Med Sci Sports Exerc 2012;44:383-391.
13.
Moxham J, Jolley C: Breathlessness, fatigue and the respiratory muscles. Clin Med 2009;9:778-782.
14.
Boulet L, O'Byrne PM: Asthma and exercise-induced bronchoconstriction in athletes. N Engl J Med 2015;372:641-648.
15.
Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469-478.
16.
Beasley R: Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-1232.
17.
Burney P, et al: Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1996;9:687-695.
18.
To T, Stanojevic S, Moores G, et al: Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012;12:204.
19.
Ustun TB, Chatterji S, Mechbal A, et al: The World Health Surveys; in Murray CJL, Evans DB (eds): Health Systems Performance Assessment: Debates, Methods and Empiricism. Geneva, World Health Organization, 2003, pp 797-808.
20.
Wenzel SE: Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012;18:716-725.
21.
Moore WC, Meyers DA, Wenzel SE, et al: Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010;181:315-323.
22.
Hekking PW, Bel EH: Developing and emerging clinical asthma phenotypes. J Allergy Clin Immunol Pract 2014;2:671-680.
23.
McCarty JC, Ferguson BJ: Identifying asthma triggers. Otolaryngol Clin North Am 2014;47:109-118.
24.
Pavord ID, Korn S, Howarth P, et al: Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet 2012;380:651-659.
25.
Burrowes KS, De Backer J, Smallwood R, et al: Multi-scale computational models of the airways to unravel the pathophysiological mechanisms in asthma and chronic obstructive pulmonary disease (AirPROM). Interface Focus 2013;3:20120057.
26.
Hackett TL: Epithelial-mesenchymal transition in the pathophysiology of airway remodelling in asthma. Curr Opin Allergy Clin Immunol 2012;12:53-59.
27.
Doeing DC, Solway J: Airway smooth muscle in the pathophysiology and treatment of asthma. J Appl Physiol 2013;114:834-843.
28.
Farah CS, Salome CM: Asthma and obesity: a known association but unknown mechanism. Respirology 2012;17:412-421.
29.
Boyce JA, Bochner B, Finkelman FD, Rothenberg ME: Advances in mechanisms of asthma, allergy, and immunology in 2011. J Allergy Clin Immunol 2012;129:335-341.
30.
Liu MC, Hubbard WC, Proud D, et al: Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes. Am Rev Respir Dis 1991;144:51-58.
31.
Riccio MM, Proud D: Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol 1996;97:1252-1263.
32.
Peebles RS Jr, Permutt S, Togias A: Rapid reversibility of the allergen-induced pulmonary late-phase reaction by an intravenous beta2-agonist. J Appl Physiol 1998;84:1500-1505.
33.
Barnes PJ: Pathophysiology of allergic inflammation. Immunol Rev 2011;242:31-50.
34.
Price OJ, Hull JH, Backer V, et al: The impact of exercise-induced bronchoconstriction on athletic performance: a systematic review. Sports Med 2014;44:1749-1761.
35.
Wilber RL, Rundell KW, Szmedra L, et al: Incidence of exercise-induced bronchospasm in Olympic winter sport athletes. Med Sci Sports Exerc 2000;32:732-737.
36.
Parsons JP, Kaeding C, Phillips G, et al: Prevalence of exercise-induced bronchospasm in a cohort of varsity college athletes. Med Sci Sports Exerc 2007;39:1487-1492.
37.
Butenko T, Rodman J, Aldeco M, et al: Epidemiology of exercise-induced bronchoconstriction in adolescent athletes with and without asthma in Slovenia. Eur Respir J 2014;44(suppl 58):P3518.
38.
Helenius I, Haahtela T: Allergy and asthma in elite summer sport athletes. J Allergy Clin Immunol 2000;106:444-452.
39.
Parsons JP, Hallstrand TS, Mastronarde JG, et al: An official American Thoracic Society clinical practice guideline: exercise-induced bronchoconstriction. Am J Respir Crit Care Med 2013;187:1016-1027.
40.
van Veldhoven NH, Vermeer A, Bogaard JM, et al: Children with asthma and physical exercise: effects of an exercise programme. Clin Rehabil 2001;15:360-370.
41.
Silva CS, Torres LA, Rahal A, et al: Comparison of morning and afternoon exercise training for asthmatic children. Braz J Med Biol Res 2006;39:71-78.
42.
Fanelli A, Cabral AL, Neder JA, et al: Exercise training on disease control and quality of life in asthmatic children. Med Sci Sports Exerc 2007;39:1474-1480.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.